Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: Jun 16, 2025 · CIK: 1430306
| Field | Detail |
|---|---|
| Company | Tonix Pharmaceuticals Holding Corp. (TNXP) |
| Form Type | 8-K |
| Filed Date | Jun 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, reporting
Related Tickers: TNXP
TL;DR
TNXP filed an 8-K, no major news.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on June 16, 2025, reporting on other events and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Tonix Pharmaceuticals is meeting its reporting obligations with the SEC, but it does not disclose any new material information that would immediately impact the company's stock.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- June 16, 2025 (date) — Date of report
- 26 Main Street, Chatham, New Jersey 07928 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Tonix Pharmaceuticals Holding Corp.?
The primary purpose of this 8-K filing is to report on 'Other Events' and 'Financial Statements and Exhibits' as of June 16, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 16, 2025.
What is the state of incorporation for Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. is incorporated in Nevada.
What is the IRS Employer Identification Number (EIN) for Tonix Pharmaceuticals Holding Corp.?
The IRS Employer Identification Number for Tonix Pharmaceuticals Holding Corp. is 26-1434750.
Does this 8-K filing disclose any specific new material events or financial figures?
Based on the provided text, this 8-K filing is a routine report and does not appear to disclose any specific new material events or detailed financial figures beyond the standard reporting categories.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 16, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).